Ehret, Felix, Fatma Ben Abid, Victor Teatini Ribeiro, Roddy Bodden, Feres Camargo Maluf, Piero Larco-Castilla, Ludmila Macêdo Naud, Carolina Ferraz de Paula Soares, Emad Shaikh, Leonardo Valente de Camargo, and Felipe Moreira Ridolfi. “The IDEAL Trial - a Study Protocol for a Phase III Randomized, Double-Blinded Clinical Trial Assessing the Ultra-Short Antibiotic Prophylaxis of Isoniazid and Rifapentine in Non-Immunosuppressed Patients With Newly Diagnosed Latent Tuberculosis”. Principles and Practice of Clinical Research 6, no. 1 (May 21, 2020): 9–14. Accessed September 20, 2024. https://journal2.teste.pro.br/index.php/ppcrjournal/article/view/96.